Equity Overview
Price & Market Data
Price: $0.075
Daily Change: +$0.025 / 33.29%
Daily Range: $0.0519 - $0.0849
Market Cap: $105,152
Daily Volume: 6,319
Performance Metrics
1 Week: 49.90%
1 Month: 5.56%
3 Months: -32.84%
6 Months: -78.34%
1 Year: -96.98%
YTD: -6.31%
Company Details
Employees: 39
Sector: Health technology
Industry: Biotechnology
Country:
Details
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.